Pharmacotherapy Review 2022: Infectious Diseases
Pharmacotherapy Review 2022: Infectious Diseases is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.
Published: April 12, 2022
Expires: April 12, 2025
Goal:
The 2022 annual update in infectious diseases pharmacotherapy provides a concise review of newer antimicrobial agents, rapid diagnostic tests, strategies to clarify penicillin allergies, recommendations for the use of oral antimicrobial therapy and shorter durations of therapy, as well as updates on the management of persons at risk of acquiring human immunodeficiency virus (HIV) and people living with HIV.
Educational Objectives:
Upon completion of this program, participants should be better able to:
• Select treatment options for treatment and prevention of human immunodeficiency virus
• Analyze evidence supporting the use of oral antimicrobial therapy and shorter durations of therapy
• Assess characteristics of newer rapid diagnostic technologies available for use in the management of patients with infections
• Evaluate newer antimicrobial agents and assess their potential place in current management
• Differentiate among various penicillin allergy reactions as well as potential morbidities associated with documented penicillin allergy
Additional details will be posted as soon as information is available.